Summary & Overview
HCPCS G8862: No Prolonged High-Dose Corticosteroid Therapy
HCPCS Level II code G8862 identifies patients who are not receiving systemic corticosteroids at doses of at least 10 mg/day for 60 or more consecutive days. This documentation-focused code matters nationally as corticosteroid exposure influences clinical management, risk stratification, and quality reporting for conditions where long-term steroid use affects outcomes. Clear coding of corticosteroid exposure supports care coordination, utilization review, and accurate population health measurement.
Key payers included in the scope are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical meaning, typical service setting, and the national relevance of documenting prolonged corticosteroid therapy. The publication outlines common benchmarks and reporting uses for medication-exposure codes, summarizes policy and billing considerations affecting coverage and quality metrics, and places the code in clinical context for outpatient medication reconciliation workflows.
Where specific payer policies, modifiers, taxonomies, ICD-10 mappings, and related codes are required for billing or reporting, this information is noted as not provided in the input and should be referenced from payer policy manuals and official coding resources for implementation.
Billing Code Overview
HCPCS Level II code G8862 indicates patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days. This measure describes a patient population defined by corticosteroid exposure and is used to document the absence of prolonged, high-dose corticosteroid therapy.
-
Service type: Medication exposure documentation and clinical status assessment related to systemic corticosteroid therapy
-
Typical site of service: Outpatient clinic or ambulatory care settings where medication histories and chronic therapy reviews are performed
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
Scenario: A 68-year-old female with chronic obstructive pulmonary disease (COPD) and rheumatoid arthritis presents for a quality-measure review visit. Her medication history documents intermittent oral corticosteroid bursts but no continuous systemic corticosteroid therapy at or above 10 mg prednisone (or equivalent) per day for 60 or more consecutive days. The encounter verifies corticosteroid exposure and documents current management, vaccination status, bone health counseling, and plans for monitoring if systemic steroids are initiated.
Clinical Workflow:
-
Review medication list and pharmacy records for systemic corticosteroid prescriptions.
-
Assess recent problem list, flares of inflammatory disease, and pulmonary exacerbations that might prompt prolonged steroid use.
-
Document cumulative steroid dosing and confirm absence of continuous exposure of ≥10 mg/day for ≥60 consecutive days.
-
Record relevant comorbidities (osteoporosis risk, diabetes, hypertension) and counseling provided about steroid risks and alternatives.
-
Code the encounter with
G8862to indicate the patient is not receiving systemic corticosteroids at or above the specified threshold for the reporting period.
Coding Specifications
| Modifier |
|---|